Finanzwire Finanzwire
Basculer en Français
10393 Companies
217113 Keywords
146794 Articles
114955 Press releases
Headlines Articles Press releases AndzonBio2 Remove
  1. Home
  2. Companies
  3. AndzonBio2
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 05/13/2026 at 09:25, 2 hours 17 minutes ago

    AndzonBio2, University of Cambridge, and Cambridge Enterprise Collaborate on Neuroinflammation Therapeutics

    Drug Discovery Collaboration Neurodegenerative Diseases Therapeutic Development Neuroinflammation
  • PRESS RELEASE

    published on 05/13/2026 at 09:20, 2 hours 22 minutes ago

    AndzonBio2, the ALBORADA Drug Discovery Institute at the University of Cambridge and Cambridge Enterprise Announce a Collaboration to Develop First-in-Class Therapeutics for Neuroinflammation

    AndzonBio2 partners with ALBORADA Drug Discovery Institute and Cambridge Enterprise to develop innovative neuroinflammation therapeutics, targeting neurodegenerative diseases like Parkinson's and Alzheimer's
    Therapeutics Neuroinflammation AndzonBio2 ALBORADA Drug Discovery Institute Cambridge Enterprise
    Logo of AndzonBio2
Accesswire
  • Published on 05/13/2026 at 08:05, 3 hours 37 minutes ago

    Tocvan Announces New Surface Gold-Silver Results, Outlining New Target 3 Kilometers East of Main Zone at Gran Pilar Gold-Silver Project

  • Published on 05/13/2026 at 03:30, 8 hours 12 minutes ago

    Torq Resources Grants Stock Options

  • Published on 05/13/2026 at 00:00, 11 hours 42 minutes ago

    Onco-Innovations Announces Initiation of Research Collaboration within PROmAI

  • Published on 05/12/2026 at 23:35, 12 hours 7 minutes ago

    Infield Minerals Closes $1.25 Million Financing

  • Published on 05/12/2026 at 21:55, 13 hours 47 minutes ago

    UraniumX Discovery Corp Announces Option Agreement with Gold'n Futures

View all ACCESSWIRE
EQS Group
  • Published on 05/13/2026 at 11:30, 12 minutes ago

    Original-Research: CENIT AG (von GBC AG): BUY

  • Published on 05/13/2026 at 11:20, 22 minutes ago

    Benjamin Lucas appointed Chief Executive Officer of Aztec Group

  • Published on 05/13/2026 at 11:00, 42 minutes ago

    BIRKENSTOCK REPORTS FISCAL SECOND QUARTER 2026 RESULTS WITH REVENUE GROWTH OF 14% IN CONSTANT FX DESPITE WAR, TARIFFS AND INFLATION; CONFIRMS FULL-YEAR TARGET OF 13-15%

  • Published on 05/13/2026 at 10:45, 57 minutes ago

    EQS-Adhoc: Raiffeisen Bank International AG: RBI intends to increase the offer price for the planned voluntary public tender offer to EUR 26.50 per Addiko share

  • Published on 05/13/2026 at 10:05, 1 hour 37 minutes ago

    H.I.G. Capital Signs Definitive Agreement to Acquire Vitaly Group through its Portfolio Company Avanta Salud

View all EQS
Les Echos
  • Published on 05/13/2026 at 11:30, 12 minutes ago

    Game On for esports jobs: 65% globally demand more education and career pathways for pro gaming

  • Published on 05/13/2026 at 10:05, 1 hour 37 minutes ago

    Guillemot Corporation S.A. | CGM of 04/06/2026 – Availability of preparatory documents

  • Published on 05/13/2026 at 06:55, 4 hours 47 minutes ago

    Recticel Group closes the loop on PIR circularity with industrial scale recycled polyol plant

  • Published on 05/12/2026 at 18:15, 17 hours 27 minutes ago

    AXA: Information relating to the number of voting rights and shares making up the share capital on 30/04/2026

  • Published on 05/12/2026 at 18:10, 17 hours 32 minutes ago

    imerys-12-05-2026-press-release-summary-of-the-ordinary-shareholders-general-meeting-12-may-2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy